Literature DB >> 122641

Therapy for deep mycoses: an introduction.

R Vanbreuseghem1.   

Abstract

A classification of mycoses, depending upon the depth of penetration of the organism is discussed, as is the need to distinguish the true from the 'pseudo' mycoses. The development of antifungal agents is described from the first antibiotics to amphotericin B and 5-fluorocytosine. Attention is particularly focussed on the question of safety and effectiveness. Finally, it is stressed that successful antifungal treatment must depend upon determination of the exact pathological status of the patient and examples are given which relate to such clinical assessments.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 122641      PMCID: PMC1542865     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


  4 in total

1.  Amphotericin B. Old drug, new therapy.?2110.

Authors:  G Medoff; G S Kobayashi
Journal:  JAMA       Date:  1975-05-12       Impact factor: 56.272

2.  Editoral: Treatment of fungal infections.

Authors:  J A Krick; J S Remington
Journal:  Arch Intern Med       Date:  1975-02

3.  Experimental ringworm in guinea pigs: oral treatment with griseofulvin.

Authors:  J C GENTLES
Journal:  Nature       Date:  1958-08-16       Impact factor: 49.962

4.  Studies in the biochemistry of micro-organisms: Griseofulvin, C(17)H(17)O(6)Cl, a metabolic product of Penicillium griseo-fulvum Dierckx.

Authors:  A E Oxford; H Raistrick; P Simonart
Journal:  Biochem J       Date:  1939-02       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.